HOME >> MEDICINE >> NEWS
Infectious disease researchers develop basis for experimental melanoma treatment

While investigating a fungus known to cause an infection in people with AIDS, two grantees of the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), unexpectedly discovered a potential strategy for treating metastatic melanoma, one of the deadliest forms of skin cancer. The treatment approach, which involves combining an antibody with radiation, has since been further developed and is expected to enter early-stage human clinical studies in 2007.

"This is an excellent example of how scientific research in one discipline may have payoffs in a completely unpredictable way," says NIAID Director Anthony S. Fauci, M.D. "This important AIDS-related research has led to the development of a promising therapeutic strategy for a terrible cancer that affects thousands of people each year."

Arturo Casadevall, M.D., Ph.D., of the Albert Einstein College of Medicine at Yeshiva University, in New York City, and his research team began studying the biology of the skin pigment melanin to better understand why its synthesis plays a role in the process whereby certain yeast-like fungi, specifically Cryptococcus neoformans, cause disease in some people. C. neoformans can cause cryptococcosis, a potentially fatal fungal infection that can lead to inflammation of the brain and death in people with AIDS and other immunocompromised individuals.

The researchers created an infection-fighting antibody, known as a monoclonal antibody, that binds to melanin based on scientific evidence suggesting that when melanin is synthesized, it causes the immune system to react in a way that might create antibodies to fend off C. neoformans infection. Based on this finding, Dr. Casadevall theorized that melanomas might contain melanin that would allow the monoclonal antibody to deliver radiation to tumor cells. Dr. Casadevall then teamed with his colleague Ekaterina Dadachova, Ph.D., an expert in nuclear medicine a
'"/>

Contact: Kathy Stover
kstover@niaid.nih.gov
301-402-1663
NIH/National Institute of Allergy and Infectious Diseases
7-Dec-2006


Page: 1 2 3

Related medicine news :

1. Infectious disease doctors respond to President Bushs strategy on pandemic influenza
2. A broader look at cardiac CTA images often finds diseases/disorders beyond the heart
3. Smoking may strongly increase long-term risk of eye disease
4. Pot bellies linked to early signs of cardiovascular disease
5. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
6. 1 of 2 pediatric kidney disease research centers in world established
7. Reductive stress linked to heart disease
8. Obesity linked to hyperparathyroidism in chronic kidney disease
9. Wireless technology shows promise in diagnosing pediatric intestinal disease
10. Researchers link metal ions to neurodegenerative disease
11. Green tea holds promise as new treatment for inflammatory skin diseases

Post Your Comments:
(Date:10/31/2014)... BCC Research ( http://www.bccresearch.com ) reveals in its ... the U.S. indoor air quality (IAQ) market is expected to ... growth rate (CAGR) of 7% over the next five years. ... CAGR of 7.4%. , Since 2012, continuing media attention ... of infectious diseases such as bird flu and the increase ...
(Date:10/31/2014)... Boca Raton, FL (PRWEB) October 31, 2014 ... wellness company founded on the highest principles of patient ... Lifescript , a leading health and wellness website, to ... those living with diabetes. , The Diabetes Health ... tips and recipes for those living with diabetes. Content ...
(Date:10/31/2014)... News) -- Carving pumpkins and trick-or-treating may seem like ... emergency rooms in the United States every year, experts ... fifth highest number of ER visits involving children aged ... the National Electronic Injury Surveillance System. Nearly ... the American Academy of Orthopaedic Surgeons and the Pediatric ...
(Date:10/31/2014)... to generic hormone therapy medicines improves the chances that ... a new study found. "We know that hormone ... reduce recurrence by up to 50 percent," study leader ... Columbia University Medical Center in New York City, said ... by our group and others has shown that a ...
(Date:10/31/2014)... News) -- There are clear differences in the brains ... of healthy people, new research indicates. Scientists ... could help doctors diagnose this baffling condition and shed ... syndrome are often misdiagnosed or labeled as hypochondriacs. ... "we found that [chronic fatigue syndrome] patients, brains diverge ...
Breaking Medicine News(10 mins):Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 2Health News:Global Market for U.S. Indoor Air Quality (IAQ) to Reach $11.4 Billion by 2019; Equipment Market Segment Surging at 7.4% CAGR 3Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 2Health News:Med-Care Diabetic & Medical Supplies, Inc. Partners with Lifescript to Provide Online Diabetes Health Center 3Health News:Halloween at the ER Is No Treat 2Health News:Generic Drugs May Help Breast Cancer Patients Stick to Therapy 2Health News:Brain Scans Yield Clues to Chronic Fatigue Syndrome 2Health News:Brain Scans Yield Clues to Chronic Fatigue Syndrome 3
(Date:10/31/2014)... Investor-Edge has initiated coverage on the following equities: ... ABT ), Hologic Inc. (NASDAQ: HOLX ... PLC (NYSE: COV). Free research on these five companies can ... markets on Thursday, October 30, 2014, ended on a positive ... up 1.30% and the NASDAQ Composite closed at 4,566.14, up ...
(Date:10/31/2014)...  Zebra Imaging, Inc., the world,s foremost provider ... strategic partnership with the Zygote Media Group Inc., ... biomedical models for animation and visual effects, to ... maintains the world,s most comprehensive library of accurate ... development of high-end solid 3D anatomy models for ...
(Date:10/31/2014)... , Oct. 31, 2014  Australian biopharmaceutical company Specialised ... (nanoparticle albumin-bound paclitaxel) in combination with gemcitabine, will ... patients with metastatic pancreatic cancer from 1 November. ... cancer is the 5 th most common cause ... all cancer deaths, with the lowest 5-year survival of ...
Breaking Medicine Technology:Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 2Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 3Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 4Health Care Equipment Stocks Technical Insight - Medtronic, Abbott Laboratories, Hologic, ResMed, and Covidien 5Zebra Imaging and Zygote Media Partner to Bring 3D Visualization to the Medical Community 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 3Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 4Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 5Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 6Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 7Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 8
Cached News: